|01 December 2017|
|2017’s IPO Fund Raisings Have Doubled 2016 Levels|
The Straits Times Index (STI) added 1.8% for the month of November bringing its year-to-date dividend inclusive return to 23%, compared to an SGD denominated average returns of 18% for the benchmarks of Australia, Hong Kong and Japan.
During November, the Ministry of Trade and Industry (MTI) reported that Singapore's economy grew 5.2% YoY for the September 2017 quarter, the highest growth rate since the December 2013 quarter. Manufacturing was a key driver of this growth, and has continued to expand locally and internationally throughout the year as exemplified through Purchasing Managers Indices (PMI). The JP Morgan Global Manufacturing PMI™ for the month of October was 53.5, a six-and-a-half year high, with US manufacturing business conditions improving at the quickest pace since January. In Singapore, the PMI for October, at 52.6, represented its highest level since December 2009.
In addition, November saw five IPOs that made their debut on SGX. These included Keppel-KBS US REIT, Mindchamps Preschool and Cromwell European REIT on the Mainboard, and RE&S Holdings and No Signboard Holdings on Catalist.
IPOs in 2017 YTD
With one month left to go for 2017, the year has so far brought 19 Initial Public Offerings (IPOs) of which seven were listed on the Mainboard and 12 listed on Catalist. The total funds raised of the 19 IPOs over the first 11 months came to S$4.6 billion, effectively doubling the S$2.3 billion in IPO funds raised for the entire 2016.
The market capitalisation of the 19 stocks on debut is also significantly higher, totalling S$8.3 billion, compared to S$4.4 billion in 2016. In total there were 16 IPOs last year, not including the secondary listing of Top Glove Corporation Berhad and Reverse Takeovers (RTO) of China Star Food Group and Golden Energy & Resources and one Global Depository Receipt (GDR).
IPO Funds Raised (S$M) IPO Market Capitalisation (S$M)
Source: SGX (Data as of 29 November 2017).
The 19 IPOs span a number of Sectors and Industries which include Advertising, Construction & Engineering, Chemicals, Education Services, Gas Utilities, Health Care Services, HR & Employment Services, Internet & Direct Marketing Retail, Movies & Entertainment, Office REITs, Real Estate, Restaurants and Telecommunications.
Of the 19 IPOs in 2017, the three best performers from their offer price were Samurai 2k Aerosol (+470%), UnUsUaL (+278%) and Kimly (+42%). All three of the stocks were listed on the Catalist board, which provides investors access to smaller-sized, yet potentially fast-growing companies. To read a Market Update about the Catalist stocks with the highest market capitalisation growth, click here.
UnUsUaL listed in April 2017, with an offer price of 20 cents per share. Please note that the UnUsUaL bonus issue of three stocks for five stocks went ex-bonus today. This means that the stock, which closed yesterday at 75.5 cents, opened this morning at 50.5 cents.
The 19 IPOs are tabled below, sorted by market capitalisation. These 19 stocks have averaged a +45% price change since they were listed. The seven Mainboard offerings have averaged a 6% price gain from initial offer prices, whilst the 12 Catalist stocks averaged a 68% gain from initial offer prices. The median gain of the 12 Catalist stocks was 7%. To see more details on each stock in the table below click on the stock name in SGX StockFacts.
* Market Capitalisation and Price Changes are in SGD terms, prices shown are in respective trading currency.
**Please note that the UnUsUaL bonus issue of three stocks for five stocks went ex-bonus on 1 December 2017. This means that the stock, which closed yesterday at 75.5 cents, opened this morning at 50.5 cents.
Source: Bloomberg & SGX StockFacts (Data as of 30 November 2017).
Aside from the 19 IPOs this year, Chi Mei Materials Tech GDR listed in September raising US$64.913 million. In addition were three RTOs - Pacific Star Development (1C5), Hatten Land (PH0) and Capital World (1D5). The three RTOs raised more than S$60 million and their combined market capitalisation at listing came to S$765 million. There are currently two on-going RTOs now –
§ RTO of Changjiang Fertilizer Holdings Limited by WBH and CT8; and
§ RTO of SHC Catalist-listed Capital Asia Limited by MM Myanmar Pte Ltd.
Together, the GDR and three RTOs have brought the total number of new listings in the 2017 year to date on SGX to 23.
Catalist Board Recently Celebrated its 10 year Anniversary
The SGX board Catalist was launched in November 2007 with a vision to provide high-growth companies access to growth capital more efficiently and faster time-to-market. The sponsor-supervised regime with no prescribed quantitative criteria has enabled companies at varying stages of growth and sizes to tap the capital market to propel to the next growth stage.
As noted in Catalist offer documents, companies listed on Catalist may carry higher investment risk when compared with larger or more established companies listed on the Mainboard. Furthermore, companies may list on Catalist without a track record of profitability and there is no assurance that there will be a liquid market in the shares or units of shares traded on Catalist. These offer documents point out that investors should be aware of the risks of investing in such companies and should make the decision to invest only after careful consideration and, if appropriate, consultation with professional advisers.
The quotation, trading and settlement processes of a stock listed on Catalist are identical to that of a stock listed on the Mainboard. Participation in Catalist stocks over the past few years has positioned Catalist as the most liquid platform among comparable growth platforms across the world.
Did you Know?
SGX has two listing platforms: the Mainboard – for established businesses; and Catalist for potentially fast-growing companies. There is no quantitative entry criteria required by SGX for Catalist stocks, and businesses seeking a primary listing on Catalist must be brought to list by approved Sponsors. To help facilitate the growth of the business, Catalist provides a greater scope for secondary fund raisings and easier acquisitions.
|My Gateway & SGX StockFacts|
SGX’s investor education portal with market, product and investment information and events. Sign up now at sgx.com/mygateway to receive our investment updates and economic calendar.
Whether you are seeking new or established companies to invest in, SGX StockFacts can provide you with the information you need to identify and understand the stocks that best fit your investment strategy. Visit now at sgx.com/stockfacts.
This document is not intended for distribution to, or for use by or to be acted on by any person or entity located in any jurisdiction where such distribution, use or action would be contrary to applicable laws or regulations or would subject Singapore Exchange Limited (“SGX”) to any registration or licensing requirement. This document is not an offer or solicitation to buy or sell, nor financial advice or recommendation for any investment product. This document is for general circulation only. It does not address the specific investment objectives, financial situation or particular needs of any person. Advice should be sought from a financial adviser regarding the suitability of any investment product before investing or adopting any investment strategies. Use of and/or reliance on this document is entirely at the reader’s own risk. Further information on this investment product may be obtained from www.sgx.com. Investment products are subject to significant investment risks, including the possible loss of the principal amount invested. Past performance of investment products is not indicative of their future performance. Examples provided are for illustrative purposes only. While each of SGX and its affiliates (collectively, the “SGX Group Companies”) have taken reasonable care to ensure the accuracy and completeness of the information provided, each of the SGX Group Companies disclaims any and all guarantees, representations and warranties, expressed or implied, in relation to this document and shall not be responsible or liable (whether under contract, tort (including negligence) or otherwise) for any loss or damage of any kind (whether direct, indirect or consequential losses or other economic loss of any kind, including without limitation loss of profit, loss of reputation and loss of opportunity) suffered or incurred by any person due to any omission, error, inaccuracy, incompleteness, or otherwise, any reliance on such information, or arising from and/or in connection with this document. The information in this document may have been obtained via third party sources and which have not been independently verified by any SGX Group Company. No SGX Group Company endorses or shall be liable for the content of information provided by third parties. The SGX Group Companies may deal in investment products in the usual course of their business, and may be on the opposite side of any trades. SGX is an exempt financial adviser under the Financial Advisers Act (Cap. 110) of Singapore. The information in this document is subject to change without notice. This document shall not be reproduced, republished, uploaded, linked, posted, transmitted, adapted, copied, translated, modified, edited or otherwise displayed or distributed in any manner without SGX’s prior written consent.
Nikkei owns the copyright and any other intellectual property rights in the Nikkei Stock Average itself, and the method for calculating the Nikkei Stock Average and the like. All ownership of trademarks and any other intellectual property rights with respect to marks representing "Nikkei Inc.," "Nikkei," and "Nikkei Stock Average" belongs to Nikkei. Nikkei is not obliged to continuously publish the Nikkei Stock Average, nor is it liable for any error or delay in, or discontinuation of the publication thereof. Nikkei owns the right to change the content of the Nikkei Stock Average, such as the calculation method thereof, and the right to suspend the publication thereof. Nikkei does not give any warranty, nor is it responsible for any and all financial instruments and the like, which are based on, or otherwise refer to, the Nikkei Stock Average.
All rights in the FTSE China A50 Index (the “Index”) vest in FTSE International Limited (“FTSE”). “FTSE®” is a trademark of the London Stock Exchange Group companies and is used by FTSE under license.
The SGX FTSE China A50 Index Futures (the "Product") has been developed solely by Singapore Exchange Derivatives Trading Limited. The Index is calculated by FTSE or its agent. FTSE and its licensors are not connected to and do not sponsor, advise, recommend, endorse or promote the Product and do not accept any liability whatsoever to any person arising out of (a) the use of, reliance on or any error in the Index or (b) investment in or operation of the Product. FTSE makes no claim, prediction, warranty or representation either as to the results to be obtained from the Product or the suitability of the Index for the purpose to which it is being put by Singapore Exchange Derivatives Trading Limited.
Futures or options contract on any MSCI Index are not sponsored, guaranteed, endorsed, sold or promoted by MSCI, any affiliate of MSCI or any other party involved in, or related to, making or compiling any indexes (but expressly including the exchange) MSCI bears no liability of any kind with respect to such contracts